HALO

HALOZYME THERAPEUTICS INC

Healthcare | Mid Cap

$1.22

EPS Forecast

$296.7

Revenue Forecast

Announcing earnings for the quarter ending 2025-06-30 soon
IOVAIovance Biotherapeutics IncREPLReplimune Group IncCRBUCaribou Biosciences IncRVMDRevolution Medicines IncDNLIDenali Therapeutics Inc